EUA
Viracor SARS-CoV-2 assay
FDA Emergency Use Authorization · Viracor Eurofins Clinical Diagnostics · Jan 12, 2022
Key facts
| Product | Viracor SARS-CoV-2 assay |
|---|---|
| Company | Viracor Eurofins Clinical Diagnostics |
| Product type | Real-Time RT-PCR, Pooling, Screening, Pooled Serial Screening - Swab, Multiple Targets |
| Date | Jan 12, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: